Literature DB >> 14967387

Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method versus other methods.

Joseph A Politch1, Chong Xu, Lynne Tucker, Deborah J Anderson.   

Abstract

OBJECTIVE: To compare a new sperm-processing device, utilizing a double tube and gradient, with other commonly used sperm-processing methods for their abilities to exclude human immunodeficiency virus type 1 (HIV-1) from the motile sperm fraction while retaining maximum sperm yield.
DESIGN: Laboratory experiments.
SETTING: Academic research environment. PATIENT(S): Healthy HIV-1 seronegative men between the ages of 25 and 55. INTERVENTION(S): Semen samples were spiked with HIV-1 (MN HIV-1 strain; range of concentrations: 10(-1)-10(6) TCID(50)) and subjected to one of the following sperm-processing methods: double sperm tube with discontinuous gradient of sperm separation medium formed inside (double tube gradient), conventional single tube gradient, swim-up or single tube gradient followed by swim-up (gradient/swim-up), which is the method currently used to minimize HIV-1 in semen used for assisted reproductive technology (ART) procedures. For the gradient techniques, Percoll, ISolate, and PureSperm sperm separation media were compared for efficacy of HIV-1 removal. The amount of HIV-1 remaining in the motile sperm pellet after processing was measured by reverse transcription-polymerase chain reaction (RT-PCR), NucliSens assay, or quantitative HIV-1 culture. A hemacytometer was used to microscopically assess motile sperm count. MAIN OUTCOME MEASURE(S): HIV-1 RNA copy number, decrease in HIV-1 TCID(50), motile sperm yield. RESULT(S): The double tube gradient technique was significantly better than all other methods in the removal of HIV-1 from the motile sperm fraction, and produced significantly higher sperm yields in comparison with the gradient/swim-up method. CONCLUSION(S): The double tube gradient technique is a relatively simple and effective method that reduces the risk of infection by HIV-1 while producing good sperm recovery.

Entities:  

Mesh:

Year:  2004        PMID: 14967387     DOI: 10.1016/j.fertnstert.2003.06.028

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

Review 2.  Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples.

Authors:  Ming-Yih Wu; Hong-Nerng Ho
Journal:  World J Virol       Date:  2015-05-12

Review 3.  Elimination of HIV-1 from semen and application of the processed semen to assisted reproductive technology.

Authors:  Naoaki Kuji; Yuri Mizusawa; Miwa Naganishi; Toshio Hamatani; Sokichi Iwata; Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2007-08-06

4.  Human immunodeficiency virus type-1 episomal cDNA in semen.

Authors:  Chong Xu; Joseph A Politch; Kenneth H Mayer; Deborah J Anderson
Journal:  AIDS Res Ther       Date:  2005-10-11       Impact factor: 2.250

Review 5.  HIV infection of the male genital tract--consequences for sexual transmission and reproduction.

Authors:  A Le Tortorec; N Dejucq-Rainsford
Journal:  Int J Androl       Date:  2009-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.